Literature DB >> 17676321

Is the clinical staging system a good choice in the staging of vulvar malignancies?

K Zámbó, Z Szabó, E Schmidt, M Koppán, I Répásy, J Bódis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17676321     DOI： 10.1007/s00259-007-0511-5

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  3 in total

1.  Validation and application of the sentinel lymph node concept in malignant vulvar tumours.

Authors:  Sergi Vidal-Sicart; Lluís María Puig-Tintoré; José Antonio Lejárcegui; Pilar Paredes; María Luisa Ortega; Antonio Muñoz; Jaume Ordi; Pere Fusté; Jaime Ortín; Joan Duch; Francisco Martín; Francesca Pons
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-09-28       Impact factor: 9.236

Review 2.  Sentinel lymph nodes in gynaecological malignancies: frontline between TNM and clinical staging systems?

Authors:  Katalin Zámbó; Miklós Koppán; Adrián Paál; Erzsébet Schmidt; Hans-Rudolf Tinneberg; József Bódis
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-09-11       Impact factor: 9.236

3.  Preliminary experiences with sentinel lymph node detection in cases of vulvar malignancy.

Authors:  Katalin Zámbó; Erzsébet Schmidt; Tamás Hartmann; László Kornya; Babak Dehghani; Hans Rudolf Tinneberg; József Bódis
Journal:  Eur J Nucl Med Mol Imaging       Date:  2002-07-23       Impact factor: 9.236
  3 in total
  1 in total

Review 1.  A clinicopathological review of 33 patients with vulvar melanoma identifies c-KIT as a prognostic marker.

Authors:  Viola A Heinzelmann-Schwarz; Sheri Nixdorf; Mehrnaz Valadan; Monica Diczbalis; Jake Olivier; Geoff Otton; André Fedier; Neville F Hacker; James P Scurry
Journal:  Int J Mol Med       Date:  2014-02-14       Impact factor: 4.101
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.